Assenagon Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,721,258
Closed -$15.8M 1449
2024
Q3
$15.8M Buy
+1,721,258
New +$14.2M 0.03% 409
2023
Q3
Sell
-8,299
Closed -$210K 1470
2023
Q2
$210K Buy
+8,299
New +$209K ﹤0.01% 1278
2022
Q4
Sell
-30,447
Closed -$772K 1448
2022
Q3
$772K Buy
30,447
+3,195
+12% +$112K ﹤0.01% 993
2022
Q2
$905K Buy
27,252
+15,255
+127% +$648K ﹤0.01% 1105
2022
Q1
$865K Buy
11,997
+705
+6% +$50.8K ﹤0.01% 1095
2021
Q4
$1.04M Sell
11,292
-1,387
-11% -$166K ﹤0.01% 1019
2021
Q3
$1.61M Buy
12,679
+9,638
+317% +$1.4M 0.01% 765
2021
Q2
$506K Buy
3,041
+818
+37% +$133K ﹤0.01% 1041
2021
Q1
$404K Buy
+2,223
New +$516K ﹤0.01% 1060
2020
Q4
Sell
-1,279
Closed -$280K 1249
2020
Q3
$280K Sell
1,279
-30,647
-96% -$6.49M ﹤0.01% 1038
2020
Q2
$6.09M Buy
+31,926
New +$5.59M 0.04% 285

Other funds holding TDOC

Assenagon Asset Management's TDOC Position: Q4 2024 in Review

Assenagon Asset Management sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 1,721,258 shares — an estimated $15.8M sold.

Assenagon Asset Management first reported a position in TDOC in Q2 2020 and held it in 11 quarters. The position peaked at $15.8M in Q3 2024. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Assenagon Asset Management reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 1,721,258 Teladoc Health shares in Q4 2024, an estimated $15.8M.
  • Assenagon Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 11 quarters.
  • Assenagon Asset Management's Teladoc Health position peaked at $15.8M in Q3 2024.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Assenagon Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.